Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

Exchange Traded Concepts Increases Its Investment in AbbVie by 150% - North Chicago Today

28 Mar, 2026

AbbVie: A Steady Provider of Dividend Earnings | Intellectia.AI

27 Mar, 2026

LLY vs. ABBV: Which Pharmaceutical Company May Provide Greater Growth Potential by 2026?

25 Mar, 2026

Johnson & Johnson Receives USFDA Approval for Oral Psoriasis Medication Icotyde - Medical Dialogues

19 Mar, 2026

See More